MEOBF
Price
$0.98
Change
-$0.01 (-1.01%)
Updated
Nov 13 closing price
6 days until earnings call
SPHDF
Price
$11.70
Change
-$0.00 (-0.00%)
Updated
Feb 22 closing price
Ad is loading...

MEOBF vs SPHDF

Header iconMEOBF vs SPHDF Comparison
Open Charts MEOBF vs SPHDFBanner chart's image
Mesoblast
Price$0.98
Change-$0.01 (-1.01%)
Volume$1.29K
CapitalizationN/A
Santhera Pharmaceuticals Holdings
Price$11.70
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
MEOBF vs SPHDF Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEOBF vs. SPHDF commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEOBF is a Buy and SPHDF is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (MEOBF: $0.98 vs. SPHDF: $11.70)
Brand notoriety: MEOBF and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEOBF: 374% vs. SPHDF: 100%
Market capitalization -- MEOBF: $1.14B vs. SPHDF: $115.5M
MEOBF [@Biotechnology] is valued at $1.14B. SPHDF’s [@Biotechnology] market capitalization is $115.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEOBF’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 0 green FA rating(s).

  • MEOBF’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEOBF is a better buy in the long-term than SPHDF.

Price Growth

MEOBF (@Biotechnology) experienced а +8.01% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

MEOBF is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
MEOBF($1.14B) has a higher market cap than SPHDF($116M). MEOBF YTD gains are higher at: 489.592 vs. SPHDF (0.000).
MEOBFSPHDFMEOBF / SPHDF
Capitalization1.14B116M980%
EBITDA-62.82MN/A-
Gain YTD489.5920.000-
P/E RatioN/AN/A-
Revenue5.9MN/A-
Total Cash62.6MN/A-
Total Debt119MN/A-
FUNDAMENTALS RATINGS
MEOBF vs SPHDF: Fundamental Ratings
MEOBF
SPHDF
OUTLOOK RATING
1..100
8440
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
3570
P/E GROWTH RATING
1..100
70100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHDF's Valuation (68) in the null industry is in the same range as MEOBF (88). This means that SPHDF’s stock grew similarly to MEOBF’s over the last 12 months.

SPHDF's Profit vs Risk Rating (100) in the null industry is in the same range as MEOBF (100). This means that SPHDF’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's SMR Rating (92) in the null industry is in the same range as SPHDF (100). This means that MEOBF’s stock grew similarly to SPHDF’s over the last 12 months.

MEOBF's Price Growth Rating (35) in the null industry is somewhat better than the same rating for SPHDF (70). This means that MEOBF’s stock grew somewhat faster than SPHDF’s over the last 12 months.

MEOBF's P/E Growth Rating (70) in the null industry is in the same range as SPHDF (100). This means that MEOBF’s stock grew similarly to SPHDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGNE195.551.91
+0.99%
BeiGene Ltd
SLDB5.560.05
+0.91%
Solid Biosciences
MAN63.790.38
+0.60%
ManpowerGroup
SII42.33-0.47
-1.10%
Sprott
GIPR1.83-0.07
-3.68%
Generation Income Properties

MEOBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEOBF has been loosely correlated with SPHDF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MEOBF jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
-0.72%
SPHDF - MEOBF
50%
Loosely correlated
N/A
AVTX - MEOBF
46%
Loosely correlated
+1.48%
COGT - MEOBF
39%
Loosely correlated
+0.19%
MESO - MEOBF
26%
Poorly correlated
+17.59%
KROS - MEOBF
26%
Poorly correlated
-2.79%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+0.61%
COGT - SPHDF
63%
Loosely correlated
+0.19%
MEOBF - SPHDF
50%
Loosely correlated
-0.72%
KROS - SPHDF
38%
Loosely correlated
-2.79%
CYTO - SPHDF
35%
Loosely correlated
-9.87%
More